Niigata, Japan

Sawako Goto

This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Denka Company Limited, Niigata University. Active years: 2022-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sawako Goto: Innovator in Renal Injury Prevention

Introduction

Sawako Goto is a prominent inventor based in Niigata, Japan. She has made significant contributions to the field of medicine, particularly in the prevention of kidney injuries. With a total of 2 patents, her work focuses on innovative solutions to combat renal disorders.

Latest Patents

Sawako Goto's latest patents include groundbreaking inventions aimed at preventing kidney injuries induced by hemolytic reactions. One of her notable inventions provides an inhibitor for renal injuries caused by such reactions, utilizing cilastatin or a pharmaceutically acceptable salt thereof. Another patent addresses renal injuries induced by iodinated contrast mediums, again employing cilastatin as a key component in the solution.

Career Highlights

Throughout her career, Sawako Goto has been associated with esteemed institutions such as Niigata University and Denka Company Limited. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.

Collaborations

Some of her notable coworkers include Akihiko Saito and Yoshiaki Hirayama. Their collaborative efforts have further enhanced the impact of her inventions in the medical field.

Conclusion

Sawako Goto's contributions to the prevention of kidney injuries highlight her innovative spirit and dedication to improving healthcare. Her patents represent significant advancements in medical technology, showcasing her role as a leading inventor in her field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…